Bandari Jathin has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 23000 shares of Protara Therapeutics, Inc. ($PRTO) on January 19, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Bandari Jathin | Chief Medical Officer | A | Common Stock | 23000 | $0.00 | 59,583.0000 | 11,331,338 | 62.87% | 0.20% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Bandari Jathin | Chief Medical Officer | F | Common Stock | 2879 | $1.91 | 56,704.0000 | 11,331,338 | 4.83% | 0.03% |
| Jan. 19, 2024 | Protara Therapeutics, Inc. | $PRTO | Bandari Jathin | Chief Medical Officer | A | Stock Option (Right to Buy) | 137000 | $0.00 | 137,000.0000 | 11,331,338 | 9999.99% | 1.21% |
| Jan. 10, 2024 | Protara Therapeutics, Inc. | $PRTO | Bandari Jathin | Chief Medical Officer | F | Common Stock | 1877 | $2.39 | 36,583.0000 | 11,331,338 | 4.88% | 0.02% |